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ABSTRACT 
There is increasing evidence that central noradrenaline (NA) transport mechanisms are implicated in the central nervous 
system complications of acute liver failure. In order to assess this possibility, binding sites for the high affinity NA 
transporter ligand [
3
H]-nisoxetine were measured by quantitative receptor autoradiography in the brains of rats with acute 
liver failure resulting from hepatic devascularization and in appropriate controls. In vivo microdialysis was used to measure 
extracellular brain concentrations of NA. Severe encephalopathy resulted in a significant loss of [
3
H]-nisoxetine sites in 
frontal cortex and a concomitant increase in extracellular brain concentrations of NA in rats with acute liver failure. A loss 
of transporter sites was also observed in thalamus of rats with acute liver failure. This loss of NA transporter sites could 
result from depletion of central NA stores due to a reserpine-like effect of ammonia which is known to accumulate to 
millimolar concentrations in brain in ischemic liver failure. Impaired NA transport and the consequent increase in synaptic 
concentrations and increased stimulation of neuronal and astrocytic noradrenergic receptors could be implicated in the 
pathogenesis of the encephalopathy and brain edema characteristic of acute liver failure. 
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1. INTRODUCTION 
Accumulating evidence suggests that central noradrenergic mechanisms may be implicated in the pathogenesis of the 
central nervous system complications of acute liver failure. Studies in several animal models of acute liver failure including 
hepatectomy (Hadesman et al., 1995, Tyce and Owen, 1978 and Herlin et al., 1983), liver devascularization (Murakami et 
al., 1992) and thioacetamide-induced liver injury (Yurdaydin et al., 1990) in the rat have consistently shown decreases in 
brain tissue concentrations of noradrenaline (NA). Moreover, hepatectomy results in increased NA release in 
ventriculocisternal perfusates (McKinzie et al., 1996) and in vivo microdialysis studies have shown that liver 
devascularization results in increased extracellular brain concentrations of NA as a function of the severity of 
encephalopathy (Michalak et al., 1998). These latter two findings could be the consequence of impaired high affinity uptake 
of NA into neural cells. The present study, therefore, was initiated to assess the integrity of high affinity NA transport sites 
in relation to extracellular NA concentrations in the brains of rats with acute liver failure due to hepatic devascularization. 
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2. MATERIALS AND METHODS 
2.1. Surgical techniques 
Male Sprague-Dawley rats (Charles River, St. Constant, Que., Canada) weighing 175–200 g at the time of surgery, were 
anesthetized with halothane, and an end-to-side portacaval anastomosis was performed as previously described (Michalak et 
al., 1996). The inferior vena cava was partially clamped, and an elliptical piece of vein was removed. The portal vein was 
ligated, cut and an end-to-side anastomosis (shunt: SH) was performed under a dissecting microscope, according to the 
guidelines of Lee and Fisher (1961). Total surgery time was ∼15 min. Sham-operated animals (matched for weight) were 
similarly anesthetized and, following laparotomy, the inferior vena cava and portal vein were clamped for 15 min (sham: 
SM). After surgery, the animals had free access to standard laboratory food and water. All rats were housed under constant 
conditions of temperature, humidity and light cycles. 
All experiments were in accordance with the Principles of the Guide for the Care and Use of Experimental 
Animals, vol. 2, 1984 , of the Canadian Council on Animal Care, Ottawa, and the Guiding Principles for Research 
Involving Animals and Humans  (Recommendations from the Declaration of Helsinki) approved by the Council of the 
American Physiological Society. 
2.2. Microdialysis 
24 h after portacaval shunt or laparotomy, an intracerebral guide cannula was implanted. All animals were anesthetized 
(halothane), placed in a stereotaxic frame (David Kopf Instruments, Tujunga, CA) and a disposable plastic/siliconized 
intracerebral guide cannula was inserted to the required depth through the burr hole drilled in the skull (coordinates: +3.2 
mm [sagittal], −1.5 mm [lateral], and −2.5 mm [depth] relative to the bregma (Paxinos and Watson, 1982)). The guide 
cannula was closed with a dummy probe and secured in place with dental acrylic. Total surgery time was ∼15 min. 
Throughout the surgical procedure, the temperature of animals was maintained at 37°C (CMA/150 temperature controller). 
Following recovery from anesthesia, rats were maintained in microdialysis chambers (CMA/120 system for freely-moving 
animals) with free access to rat chow and water. 
24 h after intracerebral guide cannula implantation (i.e., 48 h after shunt or sham surgery), rats were reanesthetized 
(halothane) and subjected to hepatic artery ligation (HAL) or laparotomy (SM). The dummy probe was removed from the 
intracerebral guide cannula and a microdialysis probe (CMA/12: 2 mm long, 0.5 mm diameter) was inserted into frontal 
cortex of freely-moving animals. Aortic and peritoneal catheters were implanted in all animals for arterial glucose 
monitoring, and 5% glucose (or 0.9% NaCl for control animals) was administered as needed. 
Four groups of rats were thus created: liver ischemia (SH + HAL) and the three obligate control groups (SH + SM, SM + 
HAL, SM + SM). Separate groups of rats were used for microdialysis and autoradiographic studies. Animals for the 
autoradiographic study were treated as described earlier without the intracerebral guide cannula implantation. All animals 
were evaluated every 30 min following the second surgery. 
2.3. Measurement of NA in microdialysates 
NA concentrations were measured at precoma and coma stages of encephalopathy in acute liver failure rats and at 
equivalent time points in microdialysates (described earlier). NA concentrations were measured by HPLC with 
electrochemical detection as previously described (Michalak et al., 1998). 
2.4. [3H]-nisoxetine autoradiography 
Rats were killed by decapitation and brains rapidly removed and placed in iced propanol then stored at −70°C until 
sectioning. Sagittal sections of brains from the four groups of animals described earlier were sectioned at 20 μm, mounted 
on gelatin-coated slides and stored at −20°C until use. For determination of NA transporter sites, sections were incubated 
with [
3
H]-nisoxetine (3 nM) in Tris buffer essentially as previously described (Bauer and Tejani-Butt, 1992). Non-specific 
binding was assessed by inclusion of 1 μM mazindol. Following incubation, sections were washed (×3) with ice-cold buffer, 
then water (×2), dried and apposed to [
3
H]-sensitive film for 4 weeks. Densitometric analyses of the films were performed 
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using an image analyzer (MCID system, St. Catherines, Ont., Canada). Specific binding was calculated as the difference 
between specific and non-specific binding. [
3
H]-standards were used to convert optical density measurements to binding 
sites densities expressed as pmol/g tissue. 
2.5. Statistical analyses 
Data are expressed as mean ± SEM values from at least five animals per group. Differences were compared using one-way 
ANOVA (Tukey–Kramer multiple comparisons test) and a p value of <0.05 was considered significant. 
3. RESULTS 
Rats with hepatic devascularization manifested a reproducible sequence of neurological impairment which progressed 
through diminished spontaneous activity followed by loss of righting ability (defined as the precoma stage) and ultimately 
loss of corneal reflex (coma). Rats from the three control groups showed no such neurological deterioration. 
A typical autoradiogram showing [
3
H]-nisoxetine sites in a mid-sagittal section from a control animal is shown in Fig. 1. 
 
Fig. 1. Representative autoradiogram of [3H]-nisoxetine binding sites to a sagittal section of normal rat brain. 
Note the relative uniform distribution of binding sites throughout cortical and sub-cortical regions. FCo: 
frontal cortex; Th: thalamus. 
Of particular note was the relatively high densities of [
3
H]-nisoxetine sites in dentate gyrus of the hippocampus as well as in 
thalamus and hypothalamus. This distribution of [
3
H]-nisoxetine sites in control brains was comparable to that previously 
published by others (Bauer and Tejani-Butt, 1992). 
At coma stages of encephalopathy in rats with acute liver failure, there was a significant loss of [
3
H]-nisoxetine sites in 
frontal cortex and thalamus (Table 1). 
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Table 1. Quantitative distribution of [3H]-nisoxetine binding sites in brain of rats with ischemic liver failure 
(coma stage) and of rats from the three control groupsa 
a Data shown represent mean ± SEM of duplicate determination from five rats per treatment group. Values 
significantly different from control groups indicated by ∗p<0.05 by Analysis of Variance and post-hoc 
Tukey–Kramer Test. SM: sham-operated; SH: portacaval-shunted; HAL: hepatic artery ligation. 
Measurement of extracellular (microdialysate) concentrations of NA in frontal cortex of rats with acute liver failure 
revealed a significant (46%) increase at coma stages of encephalopathy (Table 2). 
Table 2. Extracellular (microdialysate) concentrations of NA in frontal cortex of rats with acute liver failure 








a Data shown represent mean ± SEM of duplicate determinations from five rats per treatment group NA: 
noradrenaline. Values significantly different from control groups indicated by ∗p<0.05 by Analysis of 
Variance with post-hoc Tukey–Kramer Test. 
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4. DISCUSSION 
The NA transporter is an antidepressant-sensitive electrogenic transporter located on the plasma membrane of noradrenergic 
neurons (Lorang et al., 1994). It is responsible for removal of NA from the extracellular milieu of brain via an ion-
dependent transport process (Harder and Bonisch, 1985) and, in this way, terminates the action of NA in the synapse. The 
study of NA transporter regulation is nowadays facilitated by the availability of the high affinity ligand [
3
H]-nisoxetine 
which binds to a single class of sites in the rat brain (Tejani-Butt, 1992). 
Results of the present study reveal a selective loss of [
3
H]-nisoxetine sites in frontal cortex and thalamus at coma stages of 
encephalopathy in rats with acute liver failure. The finding of decreased transporter sites in frontal cortex of rats with acute 
liver failure due to hepatic devascularization offers a cogent explanation for the findings in a previous (and the present) 
study of increased NA concentrations in brain extracellular fluid of these animals at coma stages of encephalopathy 
(Michalak et al., 1998). Similar mechanisms could be implicated in hepatectomized rats in which significant increases of 
NA were described in ventriculocisternal perfusates (McKinzie et al., 1996). Whether or not the loss of thalamic transporter 
sites leads to increased extracellular NA awaits further studies. 
The mechanism whereby acute liver failure results in down-regulation of NA transporter sites is not known. One possibility 
could involve NA itself. Previous studies reveal that treatment of rats with monoamine oxidase inhibitors, which results in 
increased intracellular NA, leads to increased NA transporter sites (Lee et al., 1983) whereas depletion of brain NA 
following reserpine administration leads to reduced NA transporter sites. It is of interest in this regard that acute liver failure 
in both hepatectomized and liver devascularized rats results in decreased brain NA concentrations (Tyce and Owen, 1978, 
Herlin et al., 1983, Murakami et al., 1992 and Hadesman et al., 1995), suggesting that the decreased transporter sites could 
be the consequence of a depletion of intracellular stores of NA in the brains of these animals. Furthermore, depletion of 
monoamine stores has previously been demonstrated following exposure of rat brain synaptosomes to millimolar 
concentrations of ammonia (Erecinska et al., 1987), similar to that reported in the brains of rats with ischemic liver failure 
(Swain et al., 1992). 
Alterations in the synaptic availability of NA has been shown to contribute to neuropsychiatric disorders and 
encephalopathy. For example, evidence of altered central noradrenergic function has been described in patients with 
endogenous depression (Lechin et al., 1995) and drugs which bind to and inhibit the NA transporter are effective 
antidepressants (Barker and Blakely, 1995). Decreased brain concentrations of NA have also been described in the forebrain 
of rats with experimental septic encephalopathy (Kadoi et al., 1996). Treatment of cirrhotic patients with the adrenergic 
antagonist propranolol may precipitate encephalopathy in these patients (Tarver et al., 1983 and Weisner , 1986) and while 
this latter phenomenon has generally been attributed to a peripheral action of propranolol, central adrenergic mechanisms 
cannot be excluded. Administration of noradrenergic receptor antagonists to experimental animals results in delayed 
acquisition of motor tasks (Heron et al., 1996). A previous study showed a selective loss of α and β noradrenergic receptor 
sites in brains of rats with acute liver failure (Michalak et al., 1998) where loss of adrenergic sites was restricted to frontal 
cortex and thalamus, brain regions shown, in the present study, to express decreased amounts of NA transporter sites in 
acute liver failure. Together, these findings suggest that acute liver failure may result in a deficit in central NA synaptic 
regulation. Such changes could be implicated in the neuropsychiatric and cognitive symptoms characteristic of hepatic 
encephalopathy in patients with acute liver failure. 
The hepatic devascularized rat manifests severe brain edema at coma stages of encephalopathy (Blei et al., 1992). Brain 
edema in these animals, as in human acute liver failure, is cytotoxic in nature and is characterized by cytoplasmic swelling 
of astrocytic processes (Norenberg, 1994 and Ganz et al., 1989). Such alterations in astrocyte morphology could also be the 
consequence of altered NA transport and receptor function. Astrocytes express noradrenergic receptors both in vitro and in 
situ (Shao and Sutin, 1992) and cortical astrocytes in vitro express [
3
H]-nisoxetine binding sites which are significantly 
reduced by exposure to ammonia in concentrations equivalent to those encountered in brain in acute liver failure (Hazell 
and Butterworth, unpublished data). Exposure of cultured cortical astrocytes to these concentrations of ammonia leads to 
significant cell swelling (Norenberg, 1987). A previous study showed that depletion of brain NA by 6-hydroxydopamine 
administration resulted in significant brain edema in experimental ischemic rats (Kobayashi et al., 1990) and earlier studies 
in several animal models of acute liver failure reveal similarly decreased brain tissue concentrations of NA (Hadesman et 
al., 1995, Murakami et al., 1992 and Yurdaydin et al., 1990). Together with the results of the present study, these findings 
suggest that alterations of NA transport may be implicated in the pathogenesis of brain edema in acute liver failure. Further 
studies are required in order to assess this possibility. 
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